Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery

References

• Al-Sarraf H, Preston JE, Segal MB. (1995). The entry of acidic amino acids into brain and CSF during development, using in situ perfusion in the rat. Dev Brain Res 90:151–8
   PubMedGoogle Scholar
• Al-Sarraf H, Preston JE, Segal MB. (1997a). Acidic amino acid accumulation by rat choroid plexus during development. Dev Brain Res 102:47–52
   PubMedGoogle Scholar
• Al-Sarraf H, Preston JE, Segal MB. (1997b). Changes in the kinetics of the acidic amino acid brain and CSF uptake during development in the rat. Dev Brain Res 102:127–34
   PubMedGoogle Scholar
• Babbar AK, Singh K, Goel HC, et al. (2000). Evaluation of 99mTc labeled Photosan-3, a heamatoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy. Nucl Med Biol 27:419–26
   PubMed Web of Science ®Google Scholar
• Batchelor T, Carson K, O’Neill A, et al. (2003). Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96–07. J Clin Oncol 21:1044–9
   PubMed Web of Science ®Google Scholar
• Begleiter A, Lam H, Grover J, et al. (1979). Evidence for active transport of melphalanby amino acid carriers in L5178Y lymphoblasts in vitro. Cancer Res 39:353–9
   PubMed Web of Science ®Google Scholar
• Boado RJ, Li JY, Nagaya M, et al. (1999). Selective expression of the large neutral amino acid transporter at the blood–brain barrier. PNAS 96:12079–84
   PubMed Web of Science ®Google Scholar
• Combe B, Edno L, Lafforgue P, et al. (1995). Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients. Br J Rheumatol 34:421–8
   PubMedGoogle Scholar
• DeAngelis LM, Seiferheld W, Schold SC, et al. (2002). Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation therapy. Oncology Group Study 93-10. J Clin Oncol 20:4643–8
   PubMed Web of Science ®Google Scholar
• Deves R, Chavez P, Boyd CA. (1992). Identification of a new transport system (y + L) in human erythrocytes that recognizes lysine and leucine with high affinity. J Physiol 454:491–501
   Google Scholar
• Donehower RC, Hande KR, Drake JC, Chabner BA. (1979). Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexate. Clin Pharmacol Ther 26:63–72
   PubMed Web of Science ®Google Scholar
• Drewes LR, Conway WP, Gilboe DD. (1977). Net amino acid transport between plasma and erythrocytes and perfused dog brain. Am J Physiol 233:320–5
   PubMed Web of Science ®Google Scholar
• Erdlenbruch B, Schinkhof C, Kugler W, et al. (2003). Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. Br J Pharmacol 139:685–94
   PubMed Web of Science ®Google Scholar
• Gabathuler R. (2010). Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases. Neurobiol Dis 37:48–57
   PubMed Web of Science ®Google Scholar
• Gynther M, Jalkanen A, Lehtonen M, et al. (2010). Brain uptake of ketoprofen–lysine prodrug in rats. Int J Pharm 399:121–8
   PubMed Web of Science ®Google Scholar
• Hawkins R, DeJoseph MR, Hawkins PA. (1995). Regional brain glutamate transport in rats at normal and raised concentrations of circulating glutamate. Cell Tissue Res 281:207–14
   PubMed Web of Science ®Google Scholar
• Holmboe L, Andersen AM, Morkrid L, et al. (2012). High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients. Br J Clin Pharmacol 73:106–14
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Kelly BD, McLeod VM, et al. (2011). Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. J Control Release 152:241–8
   PubMed Web of Science ®Google Scholar
• Keller O, Keller WE, Look GV, Wersi G. (1990). Tert-butoxycarbonylation of amino acids and their derivatives: n-tert-butoxycarbonyl-l-phenylalanine organic syntheses coll. 7:70
   Google Scholar
• Kozub P, Simaljakova M. (2011). Systemic therapy of psoriasis: methotrexate. Bratisl Lek Listy 112:390–4
   PubMed Web of Science ®Google Scholar
• Laulloo SJ, Khodabocus A, Hemraz UD, Sunasee R. (2007). Use of di-tert-butyl-dicarbonate both as a protecting and activating group in the synthesis of dipeptides. Synth Commun 37:4191–7
   Web of Science ®Google Scholar
• Martin B, Posseme F, Barbier CL, et al. (2002). (Z)-1,4-Diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging: synthesis and biological evaluation. Bioorg Med Chem 10:2863–71
   PubMed Web of Science ®Google Scholar
• Miksys SL, Tyndale RF. (2002). Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 27:406–15
   PubMed Web of Science ®Google Scholar
• Miller LP, Patridge WM, Braun LD. (1985). Kinetic constants for blood—brain barrier amino acid transport in conscious rats. J Neurochem 45:1427–32
   PubMed Web of Science ®Google Scholar
• Muller M, delaPeria A, Derendrof H. (2004). Issues in pharmacokinetics and pharmacodynamics of antinfective agents: distribution to tissues. Antimicrob Agents Chemother 48:1441–53
   PubMed Web of Science ®Google Scholar
• Neuwelt EA, Diehl JT, Vu LH, et al. (1981). Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood–brain barrier disruption. Ann Intern Med 94:449–54
   PubMed Web of Science ®Google Scholar
• Norrby SR. (1985). Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime. Am J Med 79:56–61
   PubMed Web of Science ®Google Scholar
• O’Brien P, Roos D, Pratt KL, et al. (2000). Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18:519–26
   PubMed Web of Science ®Google Scholar
• O’Kane RL, Vina JR, Simpson I, et al. (2006). Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 291:412–19
   PubMed Web of Science ®Google Scholar
• Oldendorf WH. (1971). Uptake of radiolabeled essential amino acids by brain following arterial injection. Proc Soc Exp Biol Med 136:385–6
   PubMed Web of Science ®Google Scholar
• Ozeki T, Hashizawa K, Kaneko D, et al. (2010). Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel. Chem Pharm Bull 58:1142–7
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (1983). Brain metabolism: a perspective from the blood–brain barrier. Physiol Rev 63:1481–535
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2012). Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab 32:1959–72
   PubMed Web of Science ®Google Scholar
• Patridge WM, Hargreaves KM. (1988). Neutral amino acid transport at the human blood–brain barrier. J Biol Chem 263:19392–7
   PubMed Web of Science ®Google Scholar
• Perevoshchikova KA. (1960). The correlation between the active concentration of labeled amino acids by the cells, and their inclusion in the proteins of tumors and normal tissues of experimental animals in vitro. Bull Exp Biol Med 49:162–5
   Google Scholar
• Peura L, Malmioja K, Huttunen K, et al. (2013). Erratum to: Design, synthesis and brain uptake of lat1-targeted amino acid prodrugs of dopamine. Pharm Res 30:1714–17
   Web of Science ®Google Scholar
• Poulin P, Theil FP. (2000). A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. Pharm Sci 89:16–35
   PubMed Web of Science ®Google Scholar
• Rajput N, Dumka VK, Sandhu HS. (2012). Disposition kinetics and in vitro plasma protein binding of cefpirome in cattle. Vet Arhiv 82:1–9
   Web of Science ®Google Scholar
• Rao TS, Baker GB, Coutts RT. (1987). N-(3-chloropropyl) phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 11:301–8
   PubMed Web of Science ®Google Scholar
• Reddy L, Sharma R, Chuttani K. (2004). Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 6:55–64
   Web of Science ®Google Scholar
• Shingaki T, Inoue D, Furubayashi T, et al. (2010). Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Mol Pharmaceutics 7:1561–8
   PubMed Web of Science ®Google Scholar
• Simoes MF, Valente E, Gomez MJ, et al. (2009). Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis. Eur J Pharm Sci 37:257–63
   PubMed Web of Science ®Google Scholar
• Singh AP, Ramadan WM, Dahiya R, et al. (2009). Product development studies of amino acid conjugate of aceclofenac. Curr Drug Deliv 6:208–16
   PubMedGoogle Scholar
• Singhai AK, Jain S, Jain NK. (1997). Evaluation of an aqueous injection of Ketoprofen. Pharmazie 52:149–51
   PubMed Web of Science ®Google Scholar
• Smith GP. (2006). Kinetics of amine modification of proteins. Bioconjug Chem 17:501–6
   PubMed Web of Science ®Google Scholar
• Subudhi BB, Singh VK. (2014). Development of reversible glutamine conjugate of methotrexate for enhanced brain delivery. Med Chem Res. DOI: 10.1007/s00044–014–1172–0
   Google Scholar
• Voirol P, Jonzier-Perey M, Porchet F, et al. (2000). Cytochrome P-450 activities in human and rat brain microsomes. Brain Res 855:235–43
   PubMed Web of Science ®Google Scholar
• Vyas TK, Babbar AK, Sharma RK, et al. (2006). Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan. AAPS Pharm Sci Tech 7:49–57
   PubMed Web of Science ®Google Scholar
• West SG. (1997). Methotrexate hepatotoxicity. Rheum Dis Clin North Am 23:883–915
   PubMed Web of Science ®Google Scholar
• White MF. (1985). The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim Biophys Acta 822:355–74
   PubMed Web of Science ®Google Scholar
• Widemann BC, Adamson PC. (2006). Understanding and managing methotrexate nephrotoxicity. Oncologist 11:694–703
   PubMed Web of Science ®Google Scholar
• Widemann BC, Sung E, Anderson L, et al. (2000). Pharmacokinetics and metabolism of the methotrexate metabolite, 2,4-diamino-N10-methylpteroic acid. J Pharmacol Exp Ther 294:894–901
   PubMed Web of Science ®Google Scholar
• Wu G, Barth RF, Yang W, et al. (2006). Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther 5:52–9
   PubMed Web of Science ®Google Scholar
• Zhou K, Khokhar JY, Zhao B, Tyndale RF. (2013). First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo. Biochem Pharmacol 85:1848–55
   PubMed Web of Science ®Google Scholar